Blueprint Medicines Corp (BPMC) Insider Trading

Total insider buys:
  • $348,278.00
Total insider sells:
  • $145,561,399.64
Most recent insider trade:
  • Jan. 25, 2024
Most active insider trader:
  • Jeffrey W Albers
Trader NameDateTitleAmountPriceTypeTotal Value
Jan. 25, 2024Director25,000$81.91Sell$2,047,750.00
Dec. 22, 2023Insider714$90.00Sell$64,260.00
Dec. 7, 2023Insider5,000$75.00Sell$375,000.00
Dec. 4, 2023Insider600$71.43Sell$42,858.00
Nov. 30, 2023Director5,000$70.55Sell$352,750.00
Nov. 24, 2023Director15,000$67.51Sell$1,012,650.00
Nov. 3, 2023Director1,485$60.13Sell$89,293.05
Nov. 1, 2023Director3,881$60.02Sell$232,937.62
Oct. 26, 2023Insider600$56.40Sell$33,840.00
Oct. 4, 2023Insider3,769$48.06Sell$181,138.14
Sept. 28, 2023Director6,898$50.17Sell$346,072.66
Aug. 25, 2023Director10,000$50.16Sell$501,600.00
June 5, 2023Insider2,307$52.06Sell$120,102.42
March 6, 2023EVP3,322$45.68Sell$151,748.96
March 6, 2023COO3,059$45.67Sell$139,704.53
March 6, 2023Insider1,875$45.68Sell$85,650.00
March 6, 2023Director9,793$45.67Sell$447,246.31
March 6, 2023CFO3,007$45.68Sell$137,359.76
March 6, 2023CEO6,640$45.69Sell$303,381.60
Dec. 5, 2022Director20,000$50.09Sell$1,001,800.00
Nov. 3, 2022CEO1,100$43.98Buy$48,378.00
Nov. 3, 2022COO533$45.24Sell$24,112.92
Oct. 4, 2022Insider3,477$67.30Sell$234,002.10
Aug. 24, 2022Insider5,000$75.11Sell$375,550.00
Aug. 22, 2022Director8,410$70.54Sell$593,241.40
Aug. 19, 2022Director1,590$70.02Sell$111,331.80
Aug. 16, 2022Director20,000$68.41Sell$1,368,200.00
Aug. 8, 2022Director10,000$70.07Sell$700,700.00
Aug. 4, 2022SVP2,500$60.44Sell$151,100.00
June 6, 2022Insider1,908$59.76Sell$114,022.08
April 6, 2022CEO5,000$70.11Sell$350,550.00
March 16, 2022Insider2,219$60.00Sell$133,140.00
March 10, 2022Insider2,339$57.15Sell$133,673.85
March 7, 2022Insider256$56.19Sell$14,384.64
March 3, 2022Director5,000$59.98Buy$299,900.00
March 3, 2022Insider761$60.27Sell$45,865.47
Dec. 15, 2021Insider729$100.00Sell$72,900.00
Dec. 13, 2021COO1,000$98.30Sell$98,300.00
Dec. 7, 2021EVP5,000$97.30Sell$486,500.00
Nov. 15, 2021CEO30,000$114.50Sell$3,435,000.00
Nov. 15, 2021Insider729$115.49Sell$84,192.21
Nov. 3, 2021EVP5,000$110.56Sell$552,800.00
Oct. 15, 2021Insider729$102.66Sell$74,839.14
Oct. 5, 2021Insider3,241$98.18Sell$318,201.38
Sept. 23, 2021EVP25,000$108.85Sell$2,721,250.00
Sept. 23, 2021Insider600$110.00Sell$66,000.00
Aug. 19, 2021CEO25,000$92.68Sell$2,317,000.00
Aug. 17, 2021Insider1,350$91.93Sell$124,105.50
June 28, 2021COO1,000$90.24Sell$90,240.00
May 12, 2021CEO25,000$92.69Sell$2,317,250.00
First«1 of 3»Last
  • Insiders are both buying and selling Blueprint Medicines Corp stock.

  • The insider traders at Blueprint Medicines Corp are: Jeffrey W Albers, Ariel Hurley, Kate Haviland, Daniel Lynch, Marion Dorsch, George Demetri, Anthony L Boral, Nicholas Lydon, Fmr Llc, Christopher K Murray, Tracey L Mccain, Christoph Lengauer, L. Becker Hewes, Mark Alan Goldberg, Christina Rossi, Fouad Namouni, Charles A Rowland Jr, Percy H Carter, Debra Durso-Bumpus, Michael Landsittel, Mark J Levin, Rock Ventures Ii L.P. Third, Lonnel Coats, Alexis Borisy, and Kevin P. Starr

  • The most active insider trader at Blueprint Medicines Corp is Jeffrey W Albers with 37 trades.

  • Rock Ventures Ii L.P. Third has sold the most Blueprint Medicines Corp stock with a total value of $70,560,000.00.

  • Mark Alan Goldberg has bought the most Blueprint Medicines Corp stock with a total value of $599,800.00.

  • The most recent insider trade for Blueprint Medicines Corp was on Jan. 25, 2024.

  • The single biggest insider buy for Blueprint Medicines Corp was from Mark Alan Goldberg with a total value of $299,900.00 on March 3, 2022.

  • The single biggest insider sell for Blueprint Medicines Corp was from Rock Ventures Ii L.P. Third with a total value of $35,280,000.00 on Feb. 7, 2017.